Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine if topical tranexamic acid is capable of decreasing
the pigment of the dark spots left from acne bumps. The first line medication used for this
often is not tolerated well by patients, and topical tranexamic acid has minimal reported
side effects thus far.